Drug-therapy combo cuts breast cancer recurrence risk by 25%, Eli Lilly announces
Eli Lilly and Company on Sunday announced positive results on the fight against breast cancer.
x
Drug-therapy combo cuts breast cancer recurrence risk by 25%, Eli Lilly announces
Eli Lilly and Company on Sunday announced positive results on the fight against breast cancer.